That quantity may enhance Covid-19 vaccination for states by 25% and could be delivered in as shortly as one or two days within the first week, the chief government officer of the Nationwide Affiliation of County and Metropolis Well being Officers Lori Tremmel Freeman mentioned.
Vaccine administration has already been rising, with 2.2 million extra vaccinations reported Friday than the day earlier than and about 70.5 million doses given in complete, in accordance with the US Facilities for Illness Management and Prevention.
However with variants spreading and threatening to ship as soon as declining new case charges skyrocketing as soon as extra, officers hope to get forward of the unfold with sooner inoculations.
“We have had two vaccines and now it seems to be like we’re going to get three and meaning we are able to get extra doses into arms and we are able to attempt to get this horrible pandemic behind us,” Dr. Francis Collins, director of the Nationwide Institutes of Well being, advised CNN’s Wolf Blitzer.
New coronavirus instances have begun to plateau after a gentle decline, and Dr. Rochelle Walensky, director of the US Facilities for Illness Management and Prevention, warned it might be the “starting results” of extra transmissible variants having an impression.
“CDC has been sounding the alarm concerning the continued unfold of variants in the US,” she mentioned throughout a White Home briefing on Friday.
Misconceptions that Johnson & Johnson vaccine is ‘second class’
The 22 members of the FDA’s Vaccines and Associated Organic Merchandise Advisory Committee voted unanimously to advocate the Johnson & Johnson vaccine, which one member mentioned was an “simple name.”
“It clearly will get manner over the bar and it is good to have a single-dose vaccine,” mentioned Dr. Eric Rubin, editor in chief of the New England Journal of Medication and a professor on the Harvard TH Chan Faculty of Public Well being.
However some officers fear that the general public misunderstands simply how good the vaccine is and views it as “second class” — a false impression public well being leaders might want to handle.
“It is troublesome to make an apples-to-apples comparability between vaccines licensed, based mostly on information collected earlier than new variants are believed to have been in widespread circulation,” mentioned Sarah Christopherson, the coverage advocacy director on the Nationwide Ladies’s Well being Community.
Though Johnson & Johnson’s vaccine could seem to have a decrease efficacy fee than its earlier counterparts, that doesn’t make it a worse possibility as a result of the newest seems to guard towards a few of the virus variants, one other member of the committee to advocate the vaccine mentioned.
“One dose will maintain you out of the hospital, maintain you out of the intensive care unit and maintain you out of the morgue,” Dr. Paul Offit advised CNN’s Wolf Blitzer.
A number of public well being consultants advised Congress on Friday that individuals who have the Johnson & Johnson vaccine made out there to them ought to get it.
“If I had a J&J vaccine out there at the moment and a Moderna vaccine out there tomorrow, I might be completely happy to take the J&J at the moment. I do not really feel like I would want to attend. They’re all terrific vaccines for the issues that we care about,” Dr. Ashish Jha, Dean of the Brown College Faculty of Public Well being, advised a Home Methods and Means Well being Subcommittee listening to.
Not the time to vary doses
Promising information has additionally come out for the Pfizer/BioNTech vaccine.
Only one dose can induce a robust sufficient immune response in individuals who have already had Covid-19 that it may defend from future an infection, in accordance with two new papers revealed within the journal The Lancet on Thursday.
The vaccine is at present administered as two doses, 21 days aside. The primary dose primes the immune system and the second boosts it to guard towards Covid-19.
Some officers have instructed prioritizing the administration of first doses, to extend the immune response in as many individuals as attainable shortly.
However with rising variants, now will not be the time to vary the two-dose schedule for Pfizer and Moderna vaccines, Dr. Nancy Messonnier, the director of the Nationwide Heart for Immunization and Respiratory Ailments on the CDC, mentioned in dialog with the Journal of the American Medical Affiliation on Friday.
“The vaccines have been studied and accepted, licensed, beneficial as a two-dose schedule. Our applications are constructed on that. We have communicated that to the general public,” she mentioned. “I simply do not suppose that there’s sufficient science but to inform us that it is a second to vary what we all know to be an efficient routine.”
CNN’s Jacqueline Howard, Deidre McPhillips, Lauren Mascarenhas, Nicholas Neville, Maggie Fox, Jen Christensen, Jamie Gumbrecht and Virginia Langmaid contributed to this report.